Shanghai, China

Dayuan Zhu

This inventor holds 2 USPTO granted patents. Top assignee: Chinese Academy of Sciences. Active years: 1999-2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dayuan Zhu. Retrieved from https://idiyas.com/inventor/dayuan-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 1999-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Dayuan Zhu: Innovator in Huperzine A Derivatives

Introduction

Dayuan Zhu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicinal chemistry, particularly in the development of Huperzine A derivatives. With a total of 2 patents to his name, Zhu's work has garnered attention in both academic and industrial circles.

Latest Patents

Zhu's latest patents focus on "Huperzine A derivatives, their preparation and their use." These innovations aim to enhance the therapeutic applications of Huperzine A, a compound known for its potential benefits in treating neurodegenerative diseases.

Career Highlights

Dayuan Zhu is affiliated with the Chinese Academy of Sciences, where he conducts research and development in the field of medicinal chemistry. His work has contributed to advancing the understanding and application of Huperzine A derivatives in various medical contexts.

Collaborations

Zhu has collaborated with notable colleagues, including Xican Tang and Jinlai Lin. These partnerships have facilitated the exchange of ideas and expertise, further enriching the research environment in which he operates.

Conclusion

Dayuan Zhu's innovative work in Huperzine A derivatives exemplifies the impact of dedicated research in medicinal chemistry. His contributions continue to pave the way for advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…